Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

Research Institute of the McGill University Health Centre

$1,044,226.00

Transient disruption of the blood-testis barrier using synthetic anti-claudin compounds in human and pig models: towards improving the efficiency of spermatogonial stem cell transplantation for fertility restoration in pediatric cancer survivors

FY 2023-24

Summary
Recent research progress has made many types of cancer curable. This development led to a new situation where the post-cancer quality of life became a significant concern for cancer patients. Sperm-producing process is vulnerable to anti-cancer therapies, which can lead to permanent infertility in male cancer survivors. Preservation of the ability to have children draws a particular interest in the patients, and their partners and families. For male patients, the only approach to protect their fertility is currently sperm banking. This approach, however, is not applicable to infants and boys before puberty. Thus, childhood cancer patients face a significant risk of infertility, long before they are ready to make decisions about childbearing and household formation, which also places burdens on their parents. An emerging concept of therapeutic approach to this problem is based on sperm-making stem cells. These cells continuously produce millions of sperm everyday throughout life after puberty. Although sperm production is not established in prepubertal boys, these sperm-producing stem cells do exist from the time of birth. Thus, these cells can be harvested and freeze-stored before cancer therapy, and transplanted back to the patients afterwards when they are ready to form a family. Our research aims at improving the efficiency of transplanting these cells toward making our novel approach a clinical reality.
Program
Project Grant
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
500808
Name
Nagano Makoto
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Clinical Investigation - A: Reproduction, Maternal, Child and Youth Health 2
Projecttitle
Transient disruption of the blood-testis barrier using synthetic anti-claudin compounds in human and pig models: towards improving the efficiency of spermatogonial stem cell transplantation for fertility restoration in pediatric cancer survivors
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$1,044,226
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Animal Model; Cell Delivery; Claudin; Human Organ Culture; Male Fertility Restoration; Pediatric Cancer Survivors; Spermatogenesis; Tight Junction
Abstract
Recent research progress has made many types of cancer curable. This development led to a new situation where the post-cancer quality of life became a significant concern for cancer patients. Sperm-producing process is vulnerable to anti-cancer therapies, which can lead to permanent infertility in male cancer survivors. Preservation of the ability to have children draws a particular interest in the patients, and their partners and families. For male patients, the only approach to protect their fertility is currently sperm banking. This approach, however, is not applicable to infants and boys before puberty. Thus, childhood cancer patients face a significant risk of infertility, long before they are ready to make decisions about childbearing and household formation, which also places burdens on their parents. An emerging concept of therapeutic approach to this problem is based on sperm-making stem cells. These cells continuously produce millions of sperm everyday throughout life after puberty. Although sperm production is not established in prepubertal boys, these sperm-producing stem cells do exist from the time of birth. Thus, these cells can be harvested and freeze-stored before cancer therapy, and transplanted back to the patients afterwards when they are ready to form a family. Our research aims at improving the efficiency of transplanting these cells toward making our novel approach a clinical reality.
Competitiondate
202403
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Nagano, Makoto
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,044,226~ $0~
Research Institute of the McGill University Health Ce… | Canada Spends